aiSwingX™ analyzes US filings and reports them as news investors can read.
–
0 0
Filing fact · GILD · 10-Q · 2026-08-06

Revenue

GILEAD SCIENCES, INC. (GILD) reported Revenue of USD 7,803,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).

PeriodValueVerify
2026-04-01 ~ 2026-06-30 $7,803,000,000 EDGAR ↗
2025-06-30 (comparative) $7,082,000,000 EDGAR ↗

Provenance

Company GILEAD SCIENCES, INC. · CIK 882095
Form 10-Q · Accession 0000882095-26-000031 · Filed 2026-08-06
XBRL tag us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · unit USD · duration

Values are read directly from the inline XBRL the company filed with EDGAR. The EDGAR links above point to the exact figure inside the filing document. No ratios or interpretation are added here.

Cite this

GILEAD SCIENCES, INC. (GILD) reported Revenue of USD 7,803,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).
— aiSwingX, https://aiswingx.com/n/0000882095-26-000031/RevenueFromContractWithCustomerExcludingAssessedTax

JSON: /api/v1/facts/0000882095-26-000031/RevenueFromContractWithCustomerExcludingAssessedTax

aiSwingX™ analyzes US filings and reports them as news investors can read.
–
0 0